Who is sponsoring NCT03294239?

NCT03294239 is sponsored by Assiut University.

What drugs are being tested in NCT03294239?

Interventions in NCT03294239: Transurethral extraction of bladder stone(s), percutaneous extraction of bladder stone(s).

What condition does NCT03294239 study?

NCT03294239 studies Pediatric Bladder Stones.

Is NCT03294239 still recruiting?

NCT03294239 is currently completed. Last updated 1 September 2020.

Last reviewed 2020-09-01 · How we verify

NCT03294239

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transurethral Versus Percutaneous Endoscopic Management of Bladder Stones in Boys

Completed NA Last updated 1 September 2020

What this trial tests

NA trial testing Transurethral extraction of bladder stone(s) in Pediatric Bladder Stones in 100 participants. Completed in 1 September 2020.

Timeline

1 September 2017

Primary endpoint
1 August 2020

1 September 2020

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	100
Start date	1 September 2017
Primary completion	1 August 2020
Estimated completion	1 September 2020
Sites	1 location across Egypt

Drugs / interventions tested

Transurethral extraction of bladder stone(s)
percutaneous extraction of bladder stone(s)

Conditions studied

Pediatric Bladder Stones — all drugs for Pediatric Bladder Stones →

Sponsor

Assiut University

Who can join

Adults 1 Month to 14, male only, with Pediatric Bladder Stones. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare safety and efficacy of trans urethral and per cutaneous approaches in endoscopic management of bladder stones in boys younger than 14 years

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03294239 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 1 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03294239.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing